Company / Current Assets
Altimmune, Inc. Current Assets History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$278.2M
FY2025
5-year range
$137.3M / $278.2M
FY2021-FY2025
Trend
+102.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $20M in FY2011 to $278M in FY2025.
Based on SEC 10-K filings.
$278M in FY2025 with a 5-year CAGR of +3.9%.
Improved from $210M to $278M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +13.0%
- 5-Year CAGR
- +3.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +3.9%, indicating consistent growth.
- In FY2025, current assets increased 102.7% year-over-year.
- Lowest current assets in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $278.2M | +102.7% |
| FY2024 | $137.3M | -34.5% |
| FY2023 | $209.6M | +8.7% |
| FY2022 | $192.8M | -5.5% |
| FY2021 | $204.1M | -11.3% |
| FY2020 | $230.3M | +484.5% |
| FY2019 | $39.4M | +0.1% |
| FY2018 | $39.4M | +67.8% |
| FY2017 | $23.5M | +19.6% |
| FY2011 | $19.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026